Sung Lee

Insider Reports History

Location
Brisbane, CA
Signature
/s/ Julie Fogarty, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sung Lee:

Company Role Class Num Shares Value Price $ Report Date Ownership
CYTOKINETICS INC EVP, Chief Financial Officer Common Stock 71,416 $4,479,211 $62.72 22 Dec 2025 Direct
Vir Biotechnology, Inc. EVP & Chief Financial Officer Common Stock 100,492 $993,615 $9.89 27 Mar 2024 Direct
Vir Biotechnology, Inc. EVP & Chief Financial Officer Stock Option (Right to Buy) 80,000 $122,400 $1.53 22 Feb 2024 Direct
Tango Therapeutics, Inc. Director Common Stock 10,000 $88,595 $8.86 02 Jan 2026 Direct
Tango Therapeutics, Inc. Director Stock Option (Right to Buy) 60,000 02 Jan 2026 Direct
CYTOKINETICS INC EVP, Chief Financial Officer Non-Qualified Stock Option (Right to Buy) 41,326 14 Mar 2025 Direct
CYTOKINETICS INC EVP, Chief Financial Officer Incentive Stock Option (Right to Buy) 9,016 14 Mar 2025 Direct

Insider Reports Filed by Sung Lee

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNGX Tango Therapeutics, Inc. 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 16:10
TNGX Tango Therapeutics, Inc. 02 Jan 2026 0 $0 3 Director 06 Jan 2026, 16:05
CYTK CYTOKINETICS INC 22 Dec 2025 3 -$50,490 4 EVP, Chief Financial Officer 29 Dec 2025, 16:03
CYTK CYTOKINETICS INC 03 Dec 2025 1 -$101,431 4 EVP, Chief Financial Officer 05 Dec 2025, 16:25
CYTK CYTOKINETICS INC 02 Jun 2025 1 -$154,958 4 EVP, Chief Financial Officer 03 Jun 2025, 16:02
CYTK CYTOKINETICS INC 14 Mar 2025 3 $0 4 EVP, Chief Financial Officer 18 Mar 2025, 16:24
CYTK CYTOKINETICS INC 03 Dec 2024 3 -$79,119 4 EVP, Chief Financial Officer 05 Dec 2024, 16:30
CYTK CYTOKINETICS INC 31 May 2024 2 $0 4 EVP, Chief Financial Officer 03 Jun 2024, 17:07
CYTK CYTOKINETICS INC 26 Apr 2024 0 $0 3 EVP, Chief Financial Officer 30 Apr 2024, 17:30
VIR Vir Biotechnology, Inc. 27 Mar 2024 1 -$59,404 4 EVP & Chief Financial Officer 28 Mar 2024, 12:18
VIR Vir Biotechnology, Inc. 22 Feb 2024 2 $0 4 EVP & Chief Financial Officer 26 Feb 2024, 19:32
VIR Vir Biotechnology, Inc. 27 Mar 2023 2 $0 4 Chief Financial Officer 29 Mar 2023, 17:49
VIR Vir Biotechnology, Inc. 27 Mar 2023 0 $0 3 Chief Financial Officer 29 Mar 2023, 17:47